- Category
- Medium (2023-24)
- Udyam number
- UDYAM-DD-01-0001196

About Raman & Weil Private Limited
Data last updated:
Raman & Weil Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 July 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24200MH1988PTC048181. Its GSTIN is 27AAACR5065M2Z0 (Maharashtra). The company holds 12 GST registrations, of which 6 are active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4.26 Lakh. It is led by directors Hiten Pravin Shah (Managing Director) and Bhowli Nikhil Shah.
Its last annual general meeting (AGM) was held on 28 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 36/37 3rd Floor Mittal Chamber Opp. Inox Theatre Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2025, the company reported a revenue of ₹145.87 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹14.33 Cr (net margin 9.8%) and EBITDA of ₹22.92 Cr (EBITDA margin 15.7%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.
The company has about 169 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹21.76 Cr and satisfied charges of ₹17.9 Cr on record. Court records list 13 cases involving the company, including 9 filed by the company and 4 filed against it; 3 cases are pending. The company has 5 deals on record (5 secondary share transfers); the latest was in February 2024. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Celon Laboratories Private Limited with revenue of ₹148.17 Cr.
Raman & Weil Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DD-01-0001196). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ramanweil.com.
Company details
Recognitions & Rankings of Raman & Weil
Contact details
Raman & Weil Private Limited's registered office is in Mumbai, Maharashtra. Its website is ramanweil.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address36/37 3rd Floor Mittal Chamber Opp. Inox Theatre Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Raman & Weil Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Raman & Weil is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Raman & Weil Private Limited, buy the company report.
Financials of Raman & Weil Private Limited
FY 2025 filings availableRaman & Weil Private Limited reported revenue of ₹145.87 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over three years, including 7% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.92 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.33 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.7% | ||||
| Net Profit Margin | 9.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Raman & Weil Private Limited, buy the company report.
Board of directors of Raman & Weil Private Limited
Raman & Weil has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhowli Nikhil Shah Also directs: Ark-Shah Partners LLP | Director | 21 Jul 1988 | 38 Years 3 Months | Current |
| Hiten Pravin Shah | Managing Director | 04 Apr 2005 | 21 Years 7 Months | Current |
Peer comparison
Raman & Weil Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Celon Laboratories Private Limited | ₹148.17 Cr (FY 2025) | -7.0% | Hyderabad, Telangana, India | |||
| Canton Laboratories Private Limited | ₹147.08 Cr (FY 2025) | 26.0% | Vadodara, Gujarat, India | |||
| Murli Krishna Pharma Private Limited | ₹146.68 Cr (FY 2025) | -21.0% | Pune, Maharashtra, India | |||
| Raman & Weil Private Limitedthis company | ₹145.87 Cr (FY 2025) | ₹14.33 Cr | 9.8% | 7.0% | Mumbai, Maharashtra, India | |
| Pulse Pharmaceuticals Private Limited | ₹145.08 Cr (FY 2024) | -1.0% | Hyderabad, Telangana, India | |||
| Goodway Chemicals Private Limited | ₹144.1 Cr (FY 2025) | -12.0% | Mumbai, Maharashtra, India | |||
| Immacule Lifesciences Private Limited | ₹143.18 Cr (FY 2025) | 34.0% | Nalagarh, Himachal Pradesh, India |
To see the full peer comparison of Raman & Weil Private Limited, buy the company report.
Auditor
Raman & Weil Private Limited is audited by F K MODY & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| F K MODY & CO | FY 2023 | 115205W |
Shareholding
The shareholding of Raman & Weil Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Raman & Weil Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Feb 2026 | 101244469 | Others | ₹50 Lakh | Open | |
| 28 Jan 2026 | 101241467 | Others | ₹21 Cr | Open | |
| 10 Jun 2025 | 101129824 | Others | ₹2.62 Lakh | Open | |
| 10 Jun 2025 | 101132783 | Others | ₹21.66 Lakh | Open | |
| 03 May 2025 | 101146367 | Others | ₹1.8 Lakh | Open |
To see the full charge records of Raman & Weil Private Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Raman & Weil Private Limited has 5 deals on record (5 secondary share transfers); the latest was in February 2024.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2024 | Secondary share transfer | Undisclosed | Seller: 4 individuals |
| Feb 2020 | Secondary share transfer | Undisclosed | Seller: Ramanlal Finance and Investments Pvt Ltd , 2 individuals |
| Jan 2020 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
| May 2013 | Secondary share transfer | Undisclosed | Seller: 2 individuals |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Raman & Weil Private Limited has 13 court cases on record: 9 filed by Raman & Weil, 4 filed against it. 3 cases are pending and 10 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 1 | 1 |
| District courts | 4 | 2 | 2 |
| Supreme Court | 2 | 1 | 0 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case | Filed by the company against Sirmaxo Chemicals Pvt Ltd | Disposed |
| Supreme Court | Court case (1805-Ordinary Civil Matters : Matters relating to specific performance of contract) | Filed against the company by Neon Laboratories Ltd. | Disposed |
| Bombay High Court | Writ petition | Filed against the company by Neon Laboratories Ltd. | Disposed |
| District court, Maharashtra Industrial and Lab, Maharashtra | Interim or miscellaneous application | Filed by the company against The Deputy Director Employees State Insurance Corporation and 1 other | Pending |
| District court, Jalandhar, Punjab | Commercial suit | Filed against the company by State Through Drug Inspector | Pending |
To see the full case history of Raman & Weil Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raman & Weil Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Raman & Weil has 12 GST registrations: 6 active and 6 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACR5065M2Z0 | Maharashtra | Active | 02 Aug 2017 |
| 27AAACR5065M3ZZ | Maharashtra | Active | 01 Sep 2023 |
| 36AAACR5065M1Z2 | Telangana | Active | 01 Jul 2017 |
| 26AAACR5065M1Z3 | Dadra and Nagar Haveli and Daman and Diu | Active | 01 Aug 2020 |
To see the full GST registrations and return filing status of Raman & Weil Private Limited, buy the company report.
Recent activity
Raman & Weil Private Limited has 6 board changes on record since 1988: 4 appointments and 2 cessations. The latest: Adimoolam Ramakrishna ceased to be Director on 01 Apr 2019.
19 earlier events are in the company report.
Frequently asked questions
Raman & Weil is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 July 1988 (38+ years old) and is registered under CIN U24200MH1988PTC048181.
Raman & Weil has 2 current directors:
- Hiten Pravin Shah - Managing Director
- Bhowli Nikhil Shah - Director
The latest financial statements of Raman & Weil on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Raman & Weil is 27AAACR5065M2Z0, registered in Maharashtra. The company has 12 GST registrations in all, of which 6 are active and 6 are cancelled or inactive. Other active GSTINs include 27AAACR5065M3ZZ (Maharashtra), 36AAACR5065M1Z2 (Telangana), 26AAACR5065M1Z3 (Dadra and Nagar Haveli and Daman and Diu).
The CIN (Corporate Identification Number) of Raman & Weil is U24200MH1988PTC048181. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raman & Weil has 13 court cases on record: 9 filed by the company and 4 filed against it. 3 are pending. Most are in the high courts.
Raman & Weil was incorporated on 21 July 1988, making it 38+ years old. It is registered with the Registrar of Companies, Mumbai.
Raman & Weil has 5 deals on record (5 secondary share transfers); the latest was in February 2024.
The peers of Raman & Weil by revenue are Celon Laboratories Private Limited, Canton Laboratories Private Limited, Murli Krishna Pharma Private Limited, Pulse Pharmaceuticals Private Limited, Goodway Chemicals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Adimoolam Ramakrishna ceased to be Director on 01 Apr 2019. Harsh Narendra Panalal ceased to be Director on 14 Dec 2016. Harsh Narendra Panalal was appointed as Director on 30 Mar 2015. Raman & Weil has 6 board changes on record in total.
Yes, Raman & Weil is registered as a medium enterprise under Udyam registration (number: UDYAM-DD-01-0001196).

